Search Login Register
Glial Cell Line-Derived Neurotrophic Factor
(GDNF)
Summary
Description:
The founding member of the glial cell line-derived neurotrophic factor family. It was originally characterized as a NERVE GROWTH FACTOR promoting the survival of MIDBRAIN dopaminergic NEURONS, and it has been studied as a potential treatment for PARKINSON DISEASE.
Also Known As:
GDNF; GDNF Growth Factor; Glial Cell-Line Derived Neurotrophic Factor; Glial Cell Line Derived Neurotrophic Factor; Growth Factor, GDNF
Networked: 1263
relevant articles (96 outcomes,
223 trials/studies)
for this Bio-Agent
Key Diseases for which Glial Cell Line-Derived Neurotrophic Factor is
Relevant
-
Parkinson Disease (Parkinson's Disease)
:
39 outcomes 62 studies in 329 results
-
Neurodegenerative Diseases (Neurodegenerative Disease)
:
6 outcomes 9 studies in 50 results
-
Spinal Cord Injuries (Spinal Cord Injury)
:
5 outcomes 5 studies in 49 results
-
Wounds and Injuries (Trauma)
:
5 outcomes 4 studies in 31 results
-
Brain Injuries (Brain Injury)
:
4 outcomes 4 studies in 31 results
Show All >>
Drugs Related to Glial Cell Line-Derived Neurotrophic Factor
-
Glial Cell Line-Derived Neurotrophic Factor (GDNF)
-
Brain-Derived Neurotrophic Factor (BDNF)
-
Nerve Growth Factor (NGF)
-
Dopamine (Intropin)
-
Nerve Growth Factors (Neurotrophins)
-
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
-
Retinaldehyde (Retinal)
-
Small Interfering RNA (siRNA)
-
Memantine (Namenda)
-
Uridine Diphosphate Glucose (UDP Glucose)
Show All >>
Therapies Related to Glial Cell Line-Derived Neurotrophic Factor
-
Transplantation (Transplant Recipients)
-
Tissue Therapy (Cell Therapy)
-
Transplants (Transplant)
-
Electroacupuncture
-
Microbubbles
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.